Joshua D. Woolley
Affiliations: | University of California, San Francisco, San Francisco, CA |
Area:
Opioids and FeedingGoogle:
"Joshua Woolley"Mean distance: 13.76 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Howard L. Fields | grad student | 2005 | UCSF | |
| (Opioid effects on palatability in the nucleus accumbens.) | ||||
| Daniel H. Mathalon | post-doc | 2011-2013 | UCSF School of Medicine | |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Haft SL, Downey AE, Raymond-Flesch M, et al. (2025) A systematic review of participant diversity in psychedelic-assisted psychotherapy trials. Psychiatry Research. 345: 116359 |
| Downey AE, Bradley ER, Lerche AS, et al. (2024) A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy? Psychedelic Medicine (New Rochelle, N.Y.). 2: 61-73 |
| Brown CK, De Coster L, Lee J, et al. (2024) Maternal care is associated with neural and behavioral effects of oxytocin administration during empathic accuracy in schizophrenia and controls. Psychoneuroendocrinology. 172: 107228 |
| Peled-Avron L, Aday JS, Kalafateli AL, et al. (2024) Editorial: Down the rabbit hole - the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions. Frontiers in Psychiatry. 15: 1431389 |
| Aday JS, Horton D, Fernandes-Osterhold G, et al. (2024) Psychedelic-assisted psychotherapy: where is the psychotherapy research? Psychopharmacology |
| Sakai K, Bradley ER, Zamaria JA, et al. (2024) Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms. Psychopharmacology |
| Mitchell JM, Bogenschutz M, Lilienstein A, et al. (2023) MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. Focus (American Psychiatric Publishing). 21: 315-328 |
| Khan AJ, Bradley E, O'Donovan A, et al. (2022) Psilocybin for Trauma-Related Disorders. Current Topics in Behavioral Neurosciences |
| Nishimi K, Borsari B, Tripp P, et al. (2022) Prior trauma exposure, posttraumatic stress symptoms, and COVID-19 vaccine hesitancy. Journal of Psychiatric Research. 151: 399-404 |
| Nishimi K, Borsari B, Marx BP, et al. (2022) Posttraumatic stress disorder symptoms associated with protective and risky behaviors for coronavirus disease 2019. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 41: 104-114 |